tiprankstipranks
Trending News
More News >
STELLA PHARMA CORPORATION (JP:4888)
:4888
Japanese Market

STELLA PHARMA CORPORATION (4888) Income Statement

Compare
0 Followers

STELLA PHARMA CORPORATION Income Statement

Last quarter (Q1 2025), STELLA PHARMA CORPORATION's total revenue was ¥92.40M, an increase of 50.00% from the same quarter last year. In Q1, STELLA PHARMA CORPORATION's net income was ¥-156.68M. See STELLA PHARMA CORPORATION’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 961.06M¥ 269.49M¥ 229.07M¥ 100.10M¥ 205.97M
Gross Profit
¥ 811.03M¥ 217.49M¥ 206.94M¥ 84.86M¥ 181.78M
Operating Expenses
¥ 901.27M¥ 977.60M¥ 1.01B¥ 826.76M¥ 862.34M
Depreciation and Amortization
¥ 34.72M¥ 35.04M¥ 35.05M¥ 34.13M¥ 31.45M
EBITDA
¥ -99.06M¥ -723.85M¥ -738.34M¥ -726.86M¥ -621.70M
Operating Income
¥ -90.25M¥ -760.30M¥ -806.77M¥ -741.90M¥ -680.57M
Other Income/Expenses
¥ -47.62M¥ -676.00K¥ 30.80M¥ -22.19M¥ 24.18M
Pretax Income
¥ -137.87M¥ -760.98M¥ -775.97M¥ -764.09M¥ -656.39M
Net Income
¥ -140.81M¥ -763.75M¥ -778.82M¥ -767.72M¥ -659.24M
Per Share Metrics
Basic EPS
¥ -4.22¥ -24.66¥ -26.97¥ -27.34¥ -32.90
Diluted EPS
¥ -4.22¥ -24.66¥ -26.97¥ -27.34¥ -32.90
Weighted Average Shares Outstanding
33.38M 30.98M 28.88M 28.08M 20.03M
Weighted Average Shares Outstanding (Diluted)
33.38M 30.98M 28.88M 28.08M 27.81M
Currency in JPY

STELLA PHARMA CORPORATION Earnings and Revenue History